INHAL-101

N/A

Report date: 2023/09/11 18:09:50
NME

Base Information

Drug NameINHAL-101
Drug Alias NameINHAL-101
ClassificationSmall molecules
Mechanisms of ActionBromodomain-containing protein 4 inhibitorsSerine/threonine-protein kinase mTOR inhibitorsPI3-kinase class I inhibitors
TargetsBromodomain-containing protein 4Serine/threonine-protein kinase mTORPI3-kinase class I
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesInhalis Therapeutics Sagl
China Registration ClassN/A

Develop Information

Active CompaniesInhalis Therapeutics Sagl
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A